Data and statistical analysis for GLP-1 as an adjunct to buprenorphine. May 21, 2025 - february 29, 2028. N01DA-22-2253. Task order no. 75N95025F00002 (TO26).
Active Awarded Last action
- Contract number
- 75N95025F00002
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,747,575
Award facts
- Opportunity
-
- 75N95025F00002 Solicitation number
- Contract value 100% obligated
- $1,747,574.58 Current and potential, with all options
- Completion date 51% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Rockville, MD 20850, USA
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $349,700 | |
| Original award | $1,397,875 |
About this award
The National Institute on Drug Abuse issued a delivery order to The Emmes Company, LLC on May 21, 2025, under the NIDA Data, Statistics, and Clinical Trial Support Center IDV (N01DA-22-2253) for data and statistical analysis supporting GLP-1 as an adjunct to buprenorphine. The order ceiling is $1,747,574.58, with performance through February 29, 2028.
The NIDA Data, Statistics, and Clinical Trial Support Center is a $44.3 million single-award IDV providing biostatistical analysis, data management, clinical trial coordination, and regulatory support for substance abuse treatment trials including studies on opioid use disorder, medication-assisted treatment interventions, and HEAL initiative work. Place of performance is Rockville, MD.
Pricing is cost plus fixed fee. No set-aside was used. As of FY2025, the order has generated $250,000 in invoiced labor across 1.2 FTEs, self-performed with no subcontractor involvement.
Quick answers
Who was awarded contract 75N95025F00002?
75N95025F00002 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on May 21, 2025.
How much is contract 75N95025F00002 worth?
The government has obligated $1,747,575 on 75N95025F00002.
Is contract 75N95025F00002 an order under another contract?
Yes. 75N95025F00002 is a delivery order under 75N95022D00017, an indefinite delivery contract.
Was contract 75N95025F00002 competed?
The extent of competition for 75N95025F00002 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award